Along with molecules exhibiting significant prognostic value for ccRCC patients, we identified five potential candidates, namely HNRNPK, IMMT, CANX, NPM1, and SERBP1 (Fig. 7B and Supplementary Tables 4, 5). The gene discussed is HNRNPK; the disease is nonpapillary renal cell carcinoma.